Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.022,96
0,21%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Science 37 Holdings Inc (SNCE) Science 37 Holdings Inc (SNCE) Notizie

Science 37 Holdings Inc

SNCE
5,75
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202414:00GLOBEScience 37 Delivers 22x Faster Enrollment than Traditional..
17/4/202414:00GLOBEScience 37 Provides Fully Consented Patients to Sites to..
12/3/202411:45PRNUSeMed completes tender offer for all outstanding shares of..
04/3/202412:18EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
04/3/202412:01EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
20/2/202405:16PRNUSKuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to..
12/2/202415:03EDGAR2Form SC 14D9 - Solicitation, recommendation statements
12/2/202414:16EDGAR2Form SC TO-T - Tender offer statement by Third Party
12/2/202413:45PRNUSeMed commences tender offer for Science 37
09/2/202413:49EDGAR2Form SC14D9C - Written communication relating to third party..
09/2/202413:40EDGAR2Form 8-K - Current report
30/1/202416:11EDGAR2Form SC TO-C - Written communication relating to an issuer..
29/1/202422:10EDGAR2Form SC14D9C - Written communication relating to third party..
29/1/202413:35EDGAR2Form 8-K - Current report
22/12/202322:14EDGAR2Form 8-K - Current report
12/12/202314:00GLOBEScience 37 Receives Top Honors in Everest PEAK Matrix®
07/12/202322:59GLOBEScience 37 Reports Inducement Grant Under NASDAQ Listing..
05/12/202313:03EDGAR2Form 8-K - Current report
05/12/202313:00GLOBEScience 37 Holdings, Inc. Announces 1-for-20 Reverse Stock..
29/11/202322:13EDGAR2Form 8-K - Current report
10/11/202322:39GLOBEScience 37 Reports Inducement Grant Under NASDAQ Listing..
07/11/202312:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/11/202312:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202312:02EDGAR2Form 8-K - Current report
27/10/202322:11EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202322:41GLOBEScience 37 Reports Inducement Grant Under NASDAQ Listing..
03/10/202322:15EDGAR2Form PRE 14A - Other preliminary proxy statements
20/9/202313:59GLOBEScience 37 Chief Delivery Officer, Darcy Forman, Named to..
13/9/202313:59GLOBEScience 37 Recognized in the Gartner® Hype Cycle™ for Life..
12/9/202313:59GLOBEScience 37 Named Market Leader for Global Decentralized..
15/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202313:59GLOBEScience 37 Recognized as Best Digital Health Solution..
11/8/202322:41GLOBEScience 37 Reports Inducement Grant Under NASDAQ Listing..
08/8/202312:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202312:02EDGAR2Form 8-K - Current report
11/7/202313:59GLOBESynlogic Partners with Science 37 on Pivotal Study..
07/7/202322:52GLOBEScience 37 Reports Inducement Grant Under NASDAQ Listing..
09/6/202322:51GLOBEScience 37 Reports Inducement Grant Under NASDAQ Listing..
18/5/202313:59GLOBEScience 37 Wins 2023 MedTech Breakthrough Award for "Best..
05/5/202322:53GLOBEScience 37 Reports Inducement Grant Under NASDAQ Listing..
Apertura: Min: Max:
Chiusura: 5,75

La tua Cronologia

NASDAQ
SNCE
Science 37
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network